Literature DB >> 2580126

Vasopressin and renin in high output heart failure of rats: hemodynamic effects of elevated plasma hormone levels.

G A Riegger, G Liebau, E Bauer, K Kochsiek.   

Abstract

We studied the hemodynamic effects of vasopressin and the renin-angiotensin system in an animal model of high output heart failure in conscious rats (aorto-caval fistula). We found significantly elevated levels of plasma renin concentration (p less than 0.025), norepinephrine (p less than 0.02), and up to 4 to 5 times higher values of vasopressin (p less than 0.002) in the rats with heart failure as compared with control animals. In contrast to the control rats that had a normally functioning osmoreceptor system, we found an inverse relationship between plasma osmolality and arginine vasopressin in the rats with heart failure in association with edema. Using a specific antagonist of the pressor activity of vasopressin, we found no significant effect on heart rate, mean arterial pressure, cardiac output (thermodilution), and peripheral vascular resistance in the control animals and in the rats with aorto-caval fistula. Captopril resulted in a significant fall of mean arterial pressure in the rats with shunt (p less than 0.001). The coincidence of high values of vasopressin and, in a number of animals, low plasma osmolalities and edema suggests a role of vasopressin in the formation of edema and in the development of "dilutional hypo-osmolality."

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2580126     DOI: 10.1097/00005344-198501000-00001

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  16 in total

1.  A reduction in SK channels contributes to increased activity of hypothalamic magnocellular neurons during heart failure.

Authors:  Hildebrando C Ferreira-Neto; Vinicia C Biancardi; Javier E Stern
Journal:  J Physiol       Date:  2017-08-02       Impact factor: 5.182

2.  Enhanced NMDA receptor-mediated intracellular calcium signaling in magnocellular neurosecretory neurons in heart failure rats.

Authors:  Javier E Stern; Evgeniy S Potapenko
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-06-19       Impact factor: 3.619

3.  An increased extrasynaptic NMDA tone inhibits A-type K+ current and increases excitability of hypothalamic neurosecretory neurons in hypertensive rats.

Authors:  Meng Zhang; Vinicia C Biancardi; Javier E Stern
Journal:  J Physiol       Date:  2017-05-23       Impact factor: 5.182

4.  High Output Cardiac Failure.

Authors:  Inder S. Anand; Viorel G. Florea
Journal:  Curr Treat Options Cardiovasc Med       Date:  2001-04

5.  A Functional Coupling Between Carbon Monoxide and Nitric Oxide Contributes to Increased Vasopressin Neuronal Activity in Heart Failure rats.

Authors:  Wagner L Reis; Vinicia C Biancardi; Yiqiang Zhou; Javier E Stern
Journal:  Endocrinology       Date:  2016-03-16       Impact factor: 4.736

Review 6.  Hyponatraemia: more than just a marker of disease severity?

Authors:  Robert W Schrier; Shailendra Sharma; Dmitry Shchekochikhin
Journal:  Nat Rev Nephrol       Date:  2012-11-20       Impact factor: 28.314

7.  Altered NMDA receptor-evoked intracellular Ca2+ dynamics in magnocellular neurosecretory neurons of hypertensive rats.

Authors:  Meng Zhang; Javier E Stern
Journal:  J Physiol       Date:  2017-11-15       Impact factor: 5.182

8.  Resistance to store depletion-induced endothelial injury in rat lung after chronic heart failure.

Authors:  Diego F Alvarez; Judy A King; Mary I Townsley
Journal:  Am J Respir Crit Care Med       Date:  2005-07-28       Impact factor: 21.405

Review 9.  Integration of renal sensory afferents at the level of the paraventricular nucleus dictating sympathetic outflow.

Authors:  Hong Zheng; Kaushik P Patel
Journal:  Auton Neurosci       Date:  2016-08-06       Impact factor: 3.145

10.  Vasoconstrictor role for vasopressin in experimental heart failure in the rabbit.

Authors:  L Arnolda; B P McGrath; M Cocks; C I Johnston
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.